ELI LILLY & Co — Director's Dealing 2016

Sep 1, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2016-08-31

Reporting Person: Simmons Jeffrey N (SVP&Pres. Elanco Animal Health)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-31	Common Stock	M	6556	—	Acquired	120546	Direct
2016-08-31	Common Stock	F	3033	$77.77	Disposed	117513	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-08-31	Restricted Stock Unit	$	M	6556	Disposed	2016-08-31	Common Stock (6556.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1032	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.